427
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Three-dimensional structure of human β-defensin 28 via homology modelling and molecular dynamics

, , &
Pages 90-101 | Received 19 Apr 2011, Accepted 01 Jul 2011, Published online: 17 Aug 2011
 

Abstract

The 3D structure of the human β-defensin 28 (HBD-28) has been investigated via homology modelling and molecular dynamics (MD) approach. With known high-resolution structures of HBD-2 and -3, single- and multiple-template sequence alignments are applied to find highly probable candidates for HBD-28, which are in turn refined through MD simulations in pure water and 50% trifluoroethanol/water mixture. The models obtained from homology modelling were assessed by protein structure validation software suite, which includes Procheck, MolProbity, Verify-3D and various structure validation tools. We found that modelling quality is proportionally related to the sequence alignment accuracy. In comparison with circular dichroism experimental data as well as stabilities of β-sheets and α-helix, HBD-28 with a reliable 3D structure was found.

Acknowledgements

This work was supported by Nanyang Technological University under Grant No. M58120005/M52120043 and the computational resources have been provided by the School of Chemical and Biomedical Engineering and the High Performance Computing Center at Nanyang Technological University.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.